Methylphenidate Sandoz Forðatafla 18 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate sandoz forðatafla 18 mg

sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Methylphenidate Sandoz Forðatafla 36 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate sandoz forðatafla 36 mg

sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 36 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 10 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 10 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 10 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 20 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 20 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 30 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 30 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 60 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 60 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 60 mg

Methylphenidate Medical Valley Forðatafla 54 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 54 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 54 mg

Dimethyl fumarate Neuraxpharm Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.